Urol Oncol. 2021 May;39(5):286-290. doi: 10.1016/j.urolonc.2020.12.007. Epub 2021 Jan 1.
PMID:35550107
[Tumour-stroma interactions in urothelial cancer].
Hatina J, Kripnerová M, Tuková J, Šrámek J, Dvořák P, Pešta M, Dobrá J, Babuška V, Racek J, Sobol M, Philimonenko A, Hozák P, Czuba Z, Schulz WA, Strell C, Grimm S, Jennek S, Friedrich KH.
Urologe A. 2015 Apr;54(4):516-25. doi: 10.1007/s00120-014-3754-3.
PMID:25895564
Programmed death ligand-1 (PD-L1) as a predictive marker for immunotherapy in solid tumours: a guide to immunohistochemistry implementation and interpretation.
Paver EC, Cooper WA, Colebatch AJ, Ferguson PM, Hill SK, Lum T, Shin JS, O'Toole S, Anderson L, Scolyer RA, Gupta R.
Pathology. 2021 Feb;53(2):141-156. doi: 10.1016/j.pathol.2020.10.007. Epub 2020 Dec 30.
PMID:33388161
Disappearance of Upper Urinary Tract Urothelial Carcinoma after Treatment of a Borderline Brenner Tumor: Case Report and Literature Review.
Aoun F, Kourie HR, Sirtaine N, Hawaux E.
Oncol Res Treat. 2015;38(7-8):379-81. doi: 10.1159/000433488. Epub 2015 Jun 18.